A topical gel composition comprising between about 0.005 and 1.0 % ivermectin, between about 30 and 40 % of a pharmaceutically acceptable alcohol, between about 30 and 40 % of a pharmaceutically acceptable glycol, and a pharmaceutically acceptable carrier, useful for treating Pediculosis capitis infestation in a human patient.
